Delivery Order SPE2DB22D3016-SPE2DB26FAAF6
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,374.60 for Cathflo Activase 2 mg vials, effective July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's Conshohocken, Pennsylvania facility. Cathflo Activase is a thrombolytic agent used in medical settings to restore function to occluded...
- The Defense Logistics Agency awarded a $7,481.79 delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, a thrombolytic medication used to restore function to central venous access devices. This competitively awarded, firm fixed price contract was issued on April 9, 2025, with an ultimate completion date of April 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $7,372.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 7, 2025. This non-set-aside delivery order was competitively awarded on August 6, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,051.76 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 8, 2025. This is a firm fixed price contract with no set-aside designation, awarded competitively on September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,232.63 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, effective August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This delivery order, awarded on July 14, 2025, represents a $16,342.05 firm fixed-price purchase of Cathflo Activase 2 mg vials issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The award is not a set-aside contract and carries an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its Corporate Office location. Cathflo Activase is a...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. This firm fixed-price delivery order, valued at $5,429.76, is scheduled for completion by August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for CATHFLO Activase 2 MG vials, valued at $16,841.63 under a firm fixed price contract type. This delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $2,626.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on August 14, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- This delivery order, valued at $4,524.80, was awarded to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cathflo Activase 2 mg vials. The contract is a firm fixed price, non-set-aside award funded by the Defense Logistics Agency (DLA) and is scheduled for completion by July 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader pharmaceutical...